4Schmidt BJ. Subacute delayed ascending myelopathy after low spine injury: case report and evidence of a vascular mechanism[J]. Spinal Cord, 2006,44 (5) : 322-325.
8[3]Lin R, Roseborough G, Dong Y, et al. DNA damage and repair system in spinal cord ischemia. J Vasc Surg, 2003,37:847 -858
9[4]Sader AA, Barbieri - Neto J, Sader SL, et al. The protective action of chlorpromazine on the spinal cord of rabbits submitted to ischemia and reperfusion is dose - dependent. J Cardiovasc Surg(Torino), 2002,43:827 - 831
10[6]Ip WK,Wong CK, Lam CW. Tumour necrosis factor-alpha-induced expression of intercellular adhension molecule-1 on human eosinophilic leukaemia Eol-l cells is mediateded by the activation of nuclear factor-kappaB pathway. Clin Exp Allergy, 2003, 33:242 - 248
5Al-Ghatany M, A1-Shraim M, Levi AD ,et al. Pathological features ineluding apoptosis in subaeute posttraumatie ascending myelopathy. Case report and review of the literature [ J ]. J Neurosurg Spine ,2005,2:619 -623.
6Frankel HL. Ascending cord lesion in the early stages following spinal injury[J]. Paraplegia, 1969,7:111 - 118.
7Belanger E, Picard C, Lacerte D, et al. Subacute posttraumatic ascending myelopathy after spinal cord injury. Report of three cases[J]. J Neuresurg,2000,93:294 - 299.
8Aito S, El Masry WS, Gemer HJ, et al. Ascending myelopathy in the early stage of spinal cord injury [ J ]. Spinal Cord, 1999,37 : 617 - 623.
9Visocchi M, Di Rocco F, Meglio M. Subacute clinical onset of postraumatic myelopathy[ J ]. Acta Neurochir (Wien) ,2003,9:799 - 804.
10Schmidt BJ. Subaeute delayed ascending myelopathy after low spine injury:case report and evidence of a vascular mechanism [ J ]. Spinal Cord,2006,44:322 -325.